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ABSTRACT: Zn2+ plays essential and diverse roles in numerous cellular
processes. To get a better understanding of intracellular Zn2+
homeostasis and the putative signaling role of Zn2+, various ﬂuorescent
sensors have been developed that allow monitoring of Zn2+
concentrations in single living cells in real time. Thus far, two families
of genetically encoded FRET-based Zn2+ sensors have been most widely
applied, the eCALWY sensors developed by our group and the ZapCY
sensors developed by Palmer and co-workers. Both have been
successfully used to measure cytosolic free Zn2+, but distinctly diﬀerent
concentrations have been reported when using these sensors to measure
Zn2+ concentrations in the ER and mitochondria. Here, we report the
development of a versatile alternative FRET sensor containing a de novo
Cys2His2 binding pocket that was created on the surface of the donor
and acceptor ﬂuorescent domains. This eZinCh-2 sensor binds Zn2+ with
a high aﬃnity that is similar to that of eCALWY-4 (Kd = 1 nM at pH 7.1), while displaying a substantially larger change in
emission ratio. eZinCh-2 not only provides an attractive alternative for measuring Zn2+ in the cytosol but was also successfully
used for measuring Zn2+ in the ER, mitochondria, and secretory vesicles. Moreover, organelle-targeted eZinCh-2 can also be used
in combination with the previously reported redCALWY sensors to allow multicolor imaging of intracellular Zn2+ simultaneously
in the cytosol and the ER or mitochondria.
A lthough zinc is sometimes still referred to as a “trace metalion”, zinc ions play a range of essential roles in numerous
cellular processes. In addition to serving as a cofactor in enzyme
catalysis and protein stabilization,1,2 Zn2+ ions have been
postulated to be involved in a variety of signaling processes,
ranging from a relatively well-established role in neuro-
modulation,3 insulin secretion,4,5 and fertilization6,7 to its
proposed role as a secondary messenger in intracellular
signaling.8,9 The high intrinsic aﬃnity of Zn2+ for the amino
acid side chains of cysteines, histidines, as well as carboxylic
acids makes the free Zn2+ ion a potent inhibitor of enzymes and
a potential modulator of protein−protein interactions.10−12
The level of free Zn2+ in the cytosol is therefore believed to be
tightly controlled between 100 pM and 1 nM,13−15 which is
suﬃcient for Zn2+ to bind to native Zn-binding proteins but low
enough not to interfere with normal metabolic and signaling
processes.16 The concentration of free Zn2+ can be very
diﬀerent in other parts of the cell, however, as millimolar
concentrations of total Zn2+ have been reported for secretory
vesicles in pancreatic β cells,17 oocytes,7 neuronal cells,18 and
mast cells.19 Triggered release of Zn2+ from organelles has been
implicated in transient increases in cytosolic free Zn2+,
potentially regulating the activity of regulatory enzymes such
as protein phosphatases and caspases.8,9
To get a better understanding of intracellular Zn2+
homeostasis and the putative signaling role of Zn2+, a variety
of ﬂuorescent sensors have been developed that allow
monitoring of Zn2+ concentrations in single living cells in real
time. Although small molecule sensors are still the most
commonly used imaging probes,20,21 it has proven challenging
to control their subcellular localization and concentration. In
contrast, genetically encoded, protein-based sensors can be
conveniently targeted to speciﬁc subcellular locations and, at
least in the cytosol, were found to not perturb intracellular free
Zn2+ levels.13,22,23 Thus far, two families of genetically encoded
FRET-based Zn2+ sensors have been most widely applied: the
eCALWY13 sensors developed by our group and the ZapCY
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sensors developed by Palmer and co-workers.14 These FRET-
based sensors are ratiometric and display at least a 2-fold
change in emission ratio upon binding Zn2+ at physiological
pH. Their aﬃnities have been tuned within the picomolar to
nanomolar range, and for both families red-shifted variants have
been developed to allow multiparameter imaging.24,25 The
eCALWY sensors consist of two small, CXXC-motif-containing
metal binding domains (ATOX1 and WD4), connected by a
long and ﬂexible peptide linker, which in turn are linked to self-
associating variants of cerulean and citrine. Formation of a
tetrahedral Zn2+ complex between the metal binding domains
disrupts the interaction between the ﬂuorescent domains,
resulting in a decrease in citrine/cerulean emission ratio.
Substitution of one of the cysteines by a serine in the WD4
domain decreased the Zn2+ aﬃnity from 2 pM in eCALWY-1 to
630 pM in eCALWY-4, whereas shortening of the linker
between the metal binding domains allowed more subtle
attenuation of the Zn2+ aﬃnity. Application of these eCALWY
sensors for measuring concentrations of cytosolic Zn2+ in
various cell types and organisms has shown that cytosolic Zn2+
concentrations are typically between 100 pM and 1 nM,
rendering the eCALWY-4 variant the sensor of choice for
cytosolic Zn2+ imaging. The ZapCY family of sensors contains
the ﬁrst two zinc ﬁnger domains from the Zn2+-responsive
transcriptional regulator Zap1. ZapCY1, the sensor containing
the wild-type zinc ﬁnger domains, displayed an increase in
FRET following Zn2+-induced folding of the zinc ﬁnger
domains with a Kd of 2.5 pM.
14 Consistent with the results
obtained with the eCALWY sensors, this sensor was found to
be fully saturated with Zn2+ when expressed in the cytosol of
HeLa cells. Therefore, a lower aﬃnity variant has been
constructed by replacing two of the Zn2+ coordinating residues
by histidines, yielding a sensor with a Kd of 811 pM.
14
Figure 1. Design and Zn2+ binding properties of eZinCh-2. (A) Crystal structure of green ﬂuorescent protein (PDB code: 1GFL)33 showing the
positions that were used to introduce cysteine or histidine residues. (B) eZinCh-2 sensor design containing a Cys2His2 binding pocket on the
dimerization interface of both ﬂuorescent proteins. (C) Emission spectra of eZinCh-2 before (empty) and after (Zn2+ saturated) addtion of Zn2+.
(D−G) Zn2+ titrations of eZinCh-2 at diﬀerent pH’s, showing the emission ratio of citrine over cerulean as a function of Zn2+ concentration. To
obtain picomolar to micromolar free Zn2+ concentrations, HEDTA (squares) and diﬀerent amounts of EGTA (5 mM and 1 mM, circles and
triangles, respectively) were used as buﬀering systems (Tables S2−S5). Solid lines represent a ﬁt assuming a 1:1 binding event, yielding Kd’s of 256
nM (pH 6.0), 1.03 nM (pH 7.1), 10 pM (pH 7.8), and 5 pM (pH 8.0). Measurements were performed in 150 mM MES (pH 6.0), 150 mM HEPES
(pH 7.1), or 50 mM Tris (pH 7.8 and 8.0) and 100 mM NaCl, 10% (v/v) glycerol, 0.01% Tween and 1 mM DTT at 20 °C. (H) Emission ratio of
eZinCh-2 before (gray bars) and after (white bars) the addition of Pb2+, Fe2+, Cu2+, Co2+, or Cd2+ (all 20 μM) or Mg2+ or Ca2+ (both 0.5 mM) in the
presence of 10 μM TPEN. The black bars show the emission ratio upon subsequent addition of 20 μM Zn2+.
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Both the eCALWY and ZapCY sensors have been
successfully applied to measure cytosolic free Zn2+ in a number
of diﬀerent cell types (primary cells, cell lines) originating from
various organisms (bacterial, yeast, mammalian, and plant
cells).15,22,26−28 However, while both sensors report similar
values for free Zn2+ when expressed in the cytosol, they
respond diﬀerently when targeted to other organelles such as
the ER and the mitochondria.15,28,29 ZapCY1 targeted to the
ER and mitochondria was found to be mostly Zn2+-free, which,
because of the high aﬃnity ZapCY1, would be consistent with
very low concentrations of free Zn2+ of 0.9 pM and 0.22 pM in
the ER and mitochondria, respectively. More recent studies
using the eCALWY sensors reported free Zn2+ concentrations
in the ER and mitochondria that are 2−3 orders of magnitude
higher, however.15 The reason for this strikingly diﬀerent
behavior is unclear, but one way to resolve this discrepancy is to
develop alternative FRET sensors based on a diﬀerent binding
mechanism. Another incentive for the development of
alternative FRET sensors is a need for probes with aﬃnities
that are tuned to speciﬁc applications, such as measuring the
relatively high free Zn2+ concentrations under the acidic
conditions present in secretory vesicles.
We previously reported the construction of an alternative
FRET sensor that lacked separate metal binding domains, but
in which Zn2+-coordinating amino acids were introduced
directly at the so-called dimerization interface of two
ﬂuorescent domains.30 The ﬁrst generation of these ZinCh
sensors showed a large ratiometric change upon Zn2+ binding,
but the Zn2+ aﬃnity was relatively low (Kd = 8.2 μM at pH
7.1).13 Here, we show that combining histidine and cysteine
coordination to create a Cys2His2 binding pocket on the
dimerization interface can increase the aﬃnity for Zn2+ over
1000-fold. This new sensor variant, eZinCh-2, has an aﬃnity
that is similar to that of eCALWY-4 (Kd = 1 nM at pH 7.1),
13
but a substantially larger change in emission ratio. eZinCh-2
not only provides an attractive alternative for measuring Zn2+ in
the cytosol but was also successfully used for measuring Zn2+ in
the ER, mitochondria, and even dense core secretory vesicles,
providing an independent system for assessing the free Zn2+
concentrations in these organelles. Moreover, organelle-
targeted eZinCh-2 provides an attractive sensor to be used in
combination with our previously reported red eCALWY
variants to allow multicolor imaging of intracellular Zn2+
simultaneously in the cytosol and the ER or mitochondria.
■ RESULTS AND DISCUSSION
Development and in Vitro Characterization of
eZinCh-2. In an eﬀort to create high aﬃnity Zn2+ binding
sites at the dimerization interface of the eZinCh FRET sensor,
we previously created several variants with two cysteines on
each of the two ﬂuorescent domains (C144/C206, C206/
C208, and C206/C204; Figure 1A).31 None of these variants
showed enhanced aﬃnity for Zn2+ compared to the parent
sensor eZinCh-1, which contained a single Cys at position 208.
Increased aﬃnity was observed for Cd2+, a metal ion with
similar coordination properties as Zn2+, but a larger ionic
radius.31 Modeling showed that the Cys4 binding pocket
created by displaying cysteines on a β-barrel scaﬀold in these
variants was too large to allow simultaneous coordination of
Zn2+ by all four cysteines and suggested that a binding site
consisting of a combination of cysteines and histidines might
provide a better Zn2+ binding site.32 We therefore screened a
small collection of sensor variants in which one or two of the
cysteines were mutated to histidines for increased Zn2+ aﬃnity
at pH 7.1. Three variants were found with a Zn2+ aﬃnity in the
low nanomolar range at pH 7.1 (Supporting Table 1;
Supporting Figure 1), which is 3 orders of magnitude higher
compared to the original eZinCh sensors. Only one sensor
displayed a large, 4-fold change in emission ratio, whereas the
other two showed ∼10% changes in emission ratio. This sensor
variant, which contains a cysteine at position 208 and a
histidine at position 206 on both domains, was further
characterized in vitro and will be referred to as eZinCh-2
(Figure 1). The small change in emission ratio observed for the
other two variants could be due to an unfavorable orientation of
the two ﬂuorescent domains in the Zn2+-bound state, resulting
in a low value for the orientation factor κ and relative ineﬃcient
energy transfer.
Zn2+ titration experiments were done to determine the Zn2+
aﬃnity of eZinch-2 at diﬀerent, physiologically relevant pH’s.
At pH 7.1, which is the pH of the cytosol and the ER lumen,
eZinCh-2 binds Zn2+ with a Kd of 1.0 ± 0.1 nM. This aﬃnity is
similar to that of eCALWY-4 at this pH, whereas the change in
emission ratio for eZinCh-2 is 2-fold higher (400% vs 200%).
Titrations done at pH 6, the pH representative of vesicular
conditions, yielded a Kd of 256 ± 22 nM. This aﬃnity is still 3
orders of magnitude higher than that of its predecessor eZinCh-
1, while retaining a large, 300% change in emission ratio. As
expected, increasing the pH results in stronger Zn2+ binding,
yielding Kd values of 5 and 10 pM at pH 8 and 7.8, respectively.
The aﬃnity of eZinCh-2 at pH 7.8, which is representative of
the pH in the mitochondrial matrix, is 6-fold stronger than that
of eCALWY-4. Based on these Zn2+ aﬃnities, the eZinCh-2
sensor may represent a versatile sensor to measure Zn2+ not
only in the cytosol but also in the ER, mitochondrial matrix,
and secretory vesicles. However, since the Cys2His2 site at the
dimerization interface in eZinCh-2 was created de novo, it was
important to ﬁrst assess its metal speciﬁcity. The emission ratio
of eZinCh-2 was therefore measured in the presence of a wide
variety of metal ions (20 μM or 5 mM) and 10 μM of the zinc
chelator TPEN (Figure 1G). An increase in emission ratio was
observed for Cd2+ and Pb2+, which was not unexpected as these
metal ions have similar coordination properties to Zn2+.
However, no signiﬁcant changes were observed for physio-
logical relevant metal ions such as Fe2+, Cu2+, Mg2+, or Ca2+. To
test whether these metal ions might still compete with Zn2+
binding and in this way interfere with Zn2+ sensing, the
emission ratio was also determined upon subsequent addition
of 20 μM Zn2+. None of the metals had any eﬀect on the Zn2+
binding response, however.
Using eZinCh-2 to Monitor Intracellular Free Zn2+
Concentrations in the Cytosol. Its Zn2+ aﬃnity of 1 nM
at pH 7.1, together with its 4-fold change in emission ratio,
makes eZinCh-2 an attractive alternative to eCALWY-4 and
ZapCY2 for measuring cytosolic free Zn2+ levels. The eZinCh-2
construct was cloned into a plasmid containing a CMV
promoter for transient expression, and the performance of
eZinCh-2 was tested in four diﬀerent mammalian cell lines.
HeLa and HEK293T cells were chosen because these cells were
previously used for the in situ characterization of the eCALWY
and ZapCY sensors.13,28 In addition, we also used eZinCh-2 to
determine the cytosolic free Zn2+ concentration in wild-type
(MCF-7) and tamoxifen-resistant MCF-7 (TamR) breast
cancer cell lines. These breast cancer cell lines were chosen
because previous work using small molecule ﬂuorescent sensors
reported increased levels of intracellular Zn2+ in TamR cells
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compared to wild-type MCF-7 cells.34,35 The performance of
eZinCh-2 was assessed by monitoring the response of the
eZinCh-2 sensor in single living cells to the subsequent
addition of the strong membrane-permeable Zn2+ chelator
TPEN, followed by the addition of excess Zn2+ together with
the Zn2+ speciﬁc ionophore pyrithione (Figure 2). In all cell
lines tested, a robust, 3-fold change in citrine over cerulean
emission ratio was observed between the Zn2+-depleted and
Zn2+-saturated states of the sensor. eZinCh-2 also showed
relatively fast in situ association and dissociation kinetics, and
low variability between individual cells. The determination of
Rmin and Rmax allowed calculation of the sensor occupancy at
the start of the experiment, which could be translated into a
free Zn2+ concentration using the Kd of 1 nM that was
measured in vitro. Very similar free Zn2+ concentrations of 0.87
± 0.10 nM and 0.83 ± 0.10 nM were determined for HeLa and
HEK293 cells, respectively. These numbers agree reasonably
well with values determined previously using the eCALWY and
ZapCY sensors in the same cell types. Slightly lower
concentrations of free Zn2+ were measured in wild type
MCF-7 cells (0.44 ± 0.06 nM) and TamR cells (0.65 ± 0.06
nM). These results show that cytosolic Zn2+ concentrations are
well-buﬀered and relatively constant among diﬀerent mamma-
lian cell types, in particular when one considers that cell lines
were grown under slightly diﬀerent conditions, each optimal for
that speciﬁc cell type. In addition, the increased levels of
intracellular Zn2+ that were previously reported for TamR cells,
apparently do not translate into a large increase in the
concentration of free Zn2+ in the cytosol of these cells.
Targeting of eZinCh-2 to the Endoplasmic Reticulum.
Following the robust performance of eZinCh-2 in imaging
cytosolic Zn2+, we next explored its suitability for measuring
free Zn2+ in the ER. eZinCh-2 was targeted to the lumen of the
ER by introducing a preproinsulin (PPI) signal peptide
sequence at the N-terminus and a C-terminal retention
sequence KDEL, yielding ER-eZinCh-2. Co-staining with a
commercially available ER tracker (ER-tracker Red, Life
Technologies) conﬁrmed correct targeting of ER-eZinCh-2 in
HeLa cells (Figure 3A). The addition of TPEN to HeLa cells
expressing ER-eZinCh-2 showed a decrease in emission ratio
that was stable after a few minutes. Subsequent addition of
excess Zn2+ in the presence of pyrithione resulted in an
immediate increase in emission ratio. Based on these traces, a
free Zn2+ concentration of 0.8 ± 0.6 nM was determined for the
ER in HeLa cells. The large standard error for the estimated
Zn2+ levels reﬂects relatively high cell-to-cell variability, with
some cells showing a concentration of 1.5 nM, while others
contain only 0.3 nM. Although these concentrations are slightly
lower than estimated using ER-targeted eCALWY-4,15 these
values are still at least 100-fold higher than the concentration
estimated using ZapCY1 in HeLa cells.28
Previous work by Taylor and co-workers showed increased
expression of ZIP7 in TamR cells compared to wild type MCF-
7 cells. ZIP7 is a Zn2+ transporter protein located almost
exclusively on the ER membrane. Phosphorylation of ZIP7 was
shown to activate the importer, resulting in release of Zn2+ from
the ER into the cytosol.9 To establish whether TamR cells have
increased concentrations of free Zn2+ in the ER, ER-ZinCh-2
was expressed in both wild-type MCF-7 and TamR cells
(Figure 3C,D). The addition of TPEN and excess Zn2+ showed
similar response curves to those found in HeLa cells, yielding
free ER Zn2+ concentrations of 0.54 ± 0.27 nM for MCF-7 and
0.75 ± 0.49 nM for TamR cells. Please note that Rmax was
determined using the immediate, rapid increase in emission
ratio following the addition of excess Zn2+. Control measure-
ments using ER-targeted eCALWY-4 gave similar ER Zn2+
concentrations of 0.39 ± 0.17 nM and 0.21 ± 0.05 nM for
MCF-7 and TamR cells, respectively (Supporting Figure 2).
Again, the cell-to-cell variation in free Zn2+ concentration was
found to be larger in the ER when compared to the cytosol,
which may reﬂect more eﬃcient buﬀering of the free Zn2+
concentration in the cytosol due to the presence of metal-
lothionein.
Targeting eZinCh-2 to Mitochondria and Insulin-
Secreting Vesicles. To explore whether eZinCh-2 could
also be successfully applied to other organelles, we targeted the
sensor to the mitochondrial matrix in HeLa cells and to insulin-
secreting vesicles in INS-1 (832/13) cells, a rat pancreatic beta
cell line. Targeting to the mitochondrial matrix was achieved by
introducing the N-terminal targeting sequence from cyto-
chrome c oxidase subunit VIII (Cox VIII), yielding mito-
eZinCh-2. Co-staining HeLa cells expressing mito-eZinCh-2
with MitoTracker Red (Life Technologies) conﬁrmed correct
targeting of the genetically encoded Zn2+ probe to this
compartment (Figure 4A). A robust response to the addition
of TPEN and excess Zn2+ was observed (Figure 4B), showing
an average occupancy of the sensor of 23 ± 6% (Figure 4B).
Assuming an intramitochondrial pH of 7.8, and thus a Kd of 10
pM for eZinCh-2, this number translates into a mitochondrial
Figure 2. Determination of the free cytosolic Zn2+ concentration in
diﬀerent cell types using eZinCh-2. (A−D) Responses of HeLa (A),
HEK293T (B), MCF-7 (C), and TamR (D) cells expressing eZinCh-2
to the addition of 50 μM TPEN, followed by the addition of 100 μM
Zn2+/ 5 μM pyrithione. All traces in A−D represent the average of at
least four cells after normalization of the emission ratio at t = 0. Error
bars represent SEM. (E) False colored ratiometric images of a HeLa
cell expressing eZinCh-2 in a resting state (start), after perfusion with
50 μM TPEN (+TPEN), and 100 μM ZnCl2/5 μM pyrithione (+Zn/
pyr).
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matrix Zn2+ concentration of 3.3 ± 1.2 pM. Experiments under
identical conditions in the same cells using mito-eCALWY-4
yielded a somewhat higher concentration of about 42 ± 28 pM
(Supporting Figure 3; Table S6). These mitochondrial free
Zn2+ concentrations are in between those previously reported
using eCALWY-4 (∼200 pM) in a number of cell lines and the
Figure 3. Zn2+ imaging using ER-targeted eZinCh-2 in diﬀerent cells types. (A) Fluorescent confocal images of a HeLa cell expressing ER-eZinCh-2
in the endoplasmic reticulum, costained with ER-tracker red. Pearson’s coeﬃcient, 0.936. Scale bar, 15 μm. (B−D) Responses of HeLa (B), MCF-7
(C), and TamR (D) cells expressing ER-eZinCh-2 to the addition of 50 μM TPEN, followed by the addition of 100 μM Zn2+/5 μM pyrithione. All
traces in B−D represent the average of at least four cells after normalization of the emission ratio at t = 0. Error bars represent SEM.
Figure 4. Targeting of eZinCh-2 to the mitochondrial matrix. (A) Fluorescent confocal images of a HeLa cell expressing the mitochondrial targeted
mito-eZinCh-2, costained with MitoTracker Red. Pearson’s coeﬃcient, 0.895. Scale bar, 10 μm. (B) Response of mito-eZinCh-2 expressed in HeLa
cells upon the addition of 50 μM TPEN, followed by the addition of excess 100 μM Zn2+/5 μM pyrithione. The trace in B represent the average of
four cells after normalization of the emission ratio at t = 0. Error bars represent SEM.
Figure 5. Targeting of eZinCh-2 to insulin secreting vesicles. (A) Overlay of the ﬂuorescent confocal images of INS-1 (832/13) cells expressing
vesicular targeted VAMP2-eZinCh-2, costained for insulin. Pearson’s coeﬃcient, 0.83. Scale bar, 15 μm. (C) Ratiometric response of INS-1 (832/13)
cells expressing VAMP2-eZinCh-2 to perfusion with 50 μM TPEN, or 100 μM Zn2+/5 μM pyrithione. Traces in C represent the average of 10 cells
after normalization of the emission ratio at t = 0. Error bars represent SEM.
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0.14 pM determined using the ZapCY-1 sensors.29 A value of
0.2 pM has also been reported by Thompson and co-workers
using a carbonic anhydrase based FRET sensor,36 while a
concentration of 72 pM has been determined using a small
molecule ratiometric ﬂuorescent probe targeted to the
mitochondria of NIH3T3 cells.37 Because the Zn2+ aﬃnities
of both eZinCh-2 and the other two FRET sensors are strongly
pH sensitive, it is important to note that these values will be
very dependent on the exact pH of the mitochondrial matrix,
however.
In an eﬀort to determine the free Zn2+ concentrations in
secretory vesicles, we previously targeted both the eCALWY
sensors and the eZinCh-1 sensor to insulin granules of INS-1
(832/13) cells by fusing them to the vesicle-targeted membrane
protein 2 (VAMP2). However, neither of these sensors showed
changes in emission ratio upon the addition of TPEN or Zn2+/
pyrithione. Vesicular targeting of eZinCh-2 was performed
similarly by fusion of VAMP-2 to the N-terminus of eZinCh-2.
Co-staining of VAMP2-eZinCh-2 with an insulin-speciﬁc
antibody revealed signiﬁcant localization to insulin-containing
granules as expected (Figure 5A).
Interestingly, vesicular-targeted eZinCh-2 was found to be
responsive to the addition of TPEN and Zn2+/pyrithione
(Figure 5B). A relatively slow decrease in emission ratio was
observed upon the addition of TPEN, suggesting that
prolonged incubation with TPEN is required to lower the
relatively high free Zn2+ concentration in these vesicles.
Subsequent addition of Zn2+/pyrithione induced a relatively
rapid increase in emission ratio. Although it is more diﬃcult to
determine the sensor occupancy very accurately in this case,
VAMP2-eZinCh-2 appeared to be ∼30% saturated, which,
assuming an intragranular pH of 6,38 corresponds to a free Zn2+
concentration of ∼120 nM. Also in this case, more accurate
determination of these values will require independent
assessment of the vesicular pH. Nonetheless, as far as we
know, these results represent the ﬁrst successful application of a
genetically encoded ﬂuorescent sensor for vesicular Zn2+.
Multicolor Imaging. The results shown above prove that
eZinCh-2 is a versatile Zn2+ sensor that can be applied to
monitor the free Zn2+ concentrations in a number of diﬀerent
organelles. eZinCh-2 would therefore be an attractive sensor to
use in conjunction with one of the recently developed red-
shifted cytosolic eCALWY sensors to allow simultaneous
monitoring of cytosolic and organelle Zn2+ concentrations in
a single cell. To explore the feasibility of using eZinCh-2 for
multicolor imaging, we coexpressed the cytosolic redCALWY-4
sensor with either ER-ZinCh-2 or mito-eZinCh-2 in HeLa cells.
redCALWY-4 is a red-shifted variant of eCALWY-4 in which
the original cerulean and citrine ﬂuorescent domains have been
replaced by self-associating variants of the mOrange2 and
mCherry, respectively.24 Figure 6A shows that coexpression of
cytosolic redCALWY-4 together with ER-eZinCh-2 allows
simultaneous monitoring of Zn2+ levels in both the ER and the
cytosol (Figure 6A). The response of each sensor to the
addition of TPEN or excess Zn2+ was similar to what was
observed in single sensor measurements. The addition of
TPEN resulted in an increase in acceptor/donor emission ratio
for redCALWY-4 and a decrease in acceptor/donor emission
ratio for ER-eZinCh-2, both consistent with a simultaneous
decrease in cytosolic and ER Zn2+ levels. The opposite behavior
was observed upon the addition of excess Zn2+/pyrithione.
Successful multicolor imaging was also achieved when
coexpressing redCAWY-4 with mito-eZinCh-2. Again, multi-
color imaging allowed independent monitoring of both
cytosolic and mitochondrial free Zn2+ in the same cell, with
each sensor behaving as expected based on single sensor
experiments. Because of their smaller volume, imaging in
organelles is typically more challenging than measuring in the
cytosol. In this case, the organelle Zn2+ status was more easily
measured than the cytosolic Zn2+ concentration, however. This
is partly due to the relatively low expression levels of the
redCALWY sensors, but also a testament of the robust nature
of the organelle-targeted eZinCh-2 sensors.
Conclusion. A de novo metal binding site with a remarkable
high aﬃnity for Zn2+ was created on the dimerization interface
of two ﬂuorescent domains by using a combination of cysteine
and histidine coordination. The development of the eZinCh-2
sensor did not require extensive evolution or precise tuning of
the secondary coordination sphere, suggesting that a similar
strategy could be applied to construct FRET sensors based on
diﬀerent ﬂuorescent proteins (e.g., mOrange/mCherry) or
introduce Zn2+-dependent control of other protein−protein
interactions. Although the high aﬃnity is consistent with the
formation of a Cys2His2 complex, deﬁnite proof for such
coordination should come from X-ray structure determination
and/or EXAFS. This could also help to further optimize the
Zn2+ aﬃnity. Alternatively, directed evolution could be
envisioned to identify variants of eZinCh-2 with even higher
aﬃnity or larger change in emission ratio.
eZinCh-2 provides an attractive alternative to the previously
developed FRET sensors of the eCALWY and ZapCY series
(Table S6). The lack of separate metal binding domains makes
Figure 6. Responses of HeLa cells expressing both redCALWY-4 (red) and either ER-eZinCh-2 (A) or mito-eZinCh-2 (B) (green) to the addition
of 50 μM TPEN, followed by the addition of excess 100 μM Zn2+/5 μM pyrithione. Traces in A and B represent the average of at least four cells after
normalization of the emission ratio at t = 0. Error bars represent SEM.
ACS Chemical Biology Articles
DOI: 10.1021/acschembio.5b00211
ACS Chem. Biol. XXXX, XXX, XXX−XXX
F
the sensor architecture of eZinCh-2 relatively simple, which
may explain the robust expression of eZinCh-2 in all the cell
lines we tested. The unique binding mechanism not only
ensures a large diﬀerence in FRET between the on and oﬀ state
of the sensor but also provides an opportunity to help resolve
some of the contradictory results obtained with the eCALWY
and ZapCY sensors. Although the free Zn2+ concentration in
the ER was found to be more heterogeneous than in the
cytosol, the results obtained with ER-targeted eZinCh-2 largely
conﬁrmed previous experiments using ER-targeted eCALWY-
415 and are inconsistent with the very low, sub-picomolar
concentrations of free Zn2+ determined using ZapCY1.28 When
targeted to the mitochondrial matrix eZinCh-2 reported Zn2+
concentrations that are between those reported by the
eCALWY-4 probe and the ZapCY1 probe. More deﬁnite
determination of the mitochondrial free Zn2+ concentration
should ideally also involve the experimental determination of
the mitochondrial pH, as the Zn2+ aﬃnities of these sensors are
known to be strongly pH dependent in this regime. The same
strategy is also recommended for future applications in which
eZinCh-2 is used to measure vesicular Zn2+.
■ METHODS
Cloning Strategies and Protein Expression and Puriﬁcation.
A detailed description of cloning strategies to create several eZinCh
mutants and ER and mitochondrial targeted eZinCh-2 probes, as well
as protein expression and puriﬁcation strategies, can be found in the
Supporting Information.
Zn2+ Titration Experiments. Zn2+ titrations were carried out with
1 μM of diﬀerent eZinCh variants in 2 mL of buﬀer consisting of 150
mM MES (pH 6.0), 150 mM HEPES (pH 7.1) or 50 mM Tris (pH
7.8 and 8.0), 100 mM NaCl, 10% (v/v) glycerol, 0.01% Tween, and 1
mM DTT at 20 °C.30 Diﬀerent Zn2+-chelators (HEDTA and EGTA)
were used together with increasing Zn2+ concentrations to reach the
desired free Zn2+ concentration. These free Zn2+ concentrations were
calculated using the MaxChelator program (http://maxchelator.
stanford.edu/). To determine the dissociation constants (Kd) for
Zn2+ of eZinCh-2 at diﬀerent pH’s, the emission ratio was ﬁtted as a
function of [Zn2+] using eq 1.
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In eq 1, R is the ratio of citrine (at 527 nm) to cerulean (at 475 nm)
emission, [Zn2+] is the calculated free Zn2+ concentration in M, P1 is
deﬁned as the ratiometric change upon Zn2+ binding, P2 is the ratio
(Cit/Cer) in the absence of Zn2+, and Kd is the dissociation constant
in M.
Mammalian Cell Culture and Imaging. HeLa cells were
cultured in Dulbecco’s Modiﬁed Eagle Medium (DMEM) supple-
mented with 25 mM glucose, 10% (v/v) fetal bovine serum (FBS), 2
mM glutamine, 100 U/mL penicillin, and 100 μg/mL streptomycin in
a humidiﬁed atmosphere containing 5% CO2. MCF-7 and TamR cells
were cultured in Roswell Park Memorial Institute media (RPMI),
supplemented with 5% (v/v) fetal calf serum (FCS), 2 mM glutamine,
1 mM fungizone, 100 U/mL penicillin, and 100 μg/mL streptomycin
at the same temperature and CO2 levels; for TamR cells, the media
were supplemented with 10−7 M 4-hydroxytamoxifen. For TamR cells,
developed as described previously,39 stripped fetal calf serum (SFCS)
was used instead of FBS. INS-1 (832/13) cells were cultured at 37 °C/
5% CO2 in RPMI-1640 medium containing 10% (v/v) FBS, 10 mM
HEPES, 2 mM glutamine, 1 mM sodium-pyruvate, 50 μM β-
mercaptoethanol, 100 U/mL penicillin, and 100 μg/mL streptomycin
(all from Life Technologies). Cells were seeded on glass coverslips (ø
30 mm, VWR) 1 day before transfection. About 200 000 cells were
seeded to reach a conﬂuency of ∼80% on the day of transfection.
Lipofectamine 2000 (Life Technologies) was used to carry out
transfections, following the manufacturer’s instructions. Cells were
imaged either 1 day (single sensor experiments) or 2 days (two sensor
experiments) after transfection in a HEPES buﬀer (Live Cell Imaging
Buﬀer, Life Technologies) at 37 °C. Imaging on Hek293T, HeLa,
MCF-7, and TamR cells was performed with a confocal microscope
(Leica, TCS SP5X) equipped with a 63× water immersion objective,
acousto-optical beamsplitters (AOBS), a white light laser, and a 405
nm laser. A black box was installed around the stage of the microscope
to avoid surrounding light coming in, and the temperature inside this
box was controlled at 37 °C using a temperature controller. For all
CFP-YFP based constructs, except for the vesicular targeted sensor,
cerulean was excited using the 405 nm laser. For the redCALWY-4, the
white light laser was set to 550 nm (5% of full power) to excite
mOrange2. Emission was monitored using the AOBS and avalanche
photo diode/photomultiplier tubes hybrid detectors (HyD, Leica):
cerulean (450−500), citrine (515−595 nm), mOrange2 (565−600),
and mCherry (600−630). Images were recorded at either 7.5 s
intervals (two sensor experiments) or at 5 s intervals (single sensor
experiments). Secretory granule free Zn2+ was imaged in INS1(832/
13) cells expressing VAMP2-eZinCh-2 using the protocol described in
ref 15 using an Olympus IX-70 wide-ﬁeld microscope with a 40x/
1.35NA oil immersion objective and a zyla sCMOS camera (Andor
Technology, Belfast, UK) controlled by Micromanager software.40
Excitation was provided at 433 nm using a monochromator
(Polychrome IV, Till Photonics, Munich, Germany). Emitted light
was split and ﬁltered with a Dual-View beam splitter (Photometrics,
Tucson, AZ, USA) equipped with a 505dcxn dichroic mirror and two
emission ﬁlters (Chroma Technology, Bellows Falls, VT, USA - D470/
24 for cerulean and D535/30 for citrine). Images were acquired at 3 s
intervals
Cells were perfused for a few minutes with HEPES buﬀer without
additives; next the buﬀer was changed to a HEPES buﬀer containing
50 μM N,N,N,N-tetrakis(2-pyridylmethyl)ethylenediamine (TPEN,
Sigma) for a few minutes, followed by perfusion with HEPES buﬀer
containing 100 μM ZnCl2 and 5 μM of the Zn
2+-speciﬁc ionophore 2-
mercaptopyridine N-oxide (pyrithione, Sigma). Imaging experiments
on INS1(832/13) cells were performed using KREBS buﬀer.13 All
buﬀers were kept at 37 °C during imaging using a water bath.
Image analysis was performed using ImageJ software as described
before.15,41 The steady-state ﬂuorescence intensity ratio of acceptor
over donor was measured, followed by the determination of the
minimum and maximum ratios to calculate the free Zn2+ concentration
using the following formula:
= · − −
+
K R R R R[Zn ] ( )/( )2 d min max
in which Rmin is the ratio in the Zn
2+ depleted state, after the addition
of 50 μM TPEN, and Rmax was obtained upon Zn
2+ saturation with
100 μM ZnCl2 in the presence of 5 μM pyrithione.
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